$15www.pharmatechoutlook.comISSN 2644-2787EXCELLENCE IN COLLABORATIVE RESEARCH RESULTING IN COMMERCIAL AND CLINICAL COMPOUNDSDRUG DISCOVERY AND DEVELOPMENT ED I T I O NCHEMOGENICS BIOPHARMAFRANCIS TAVARES, PRESIDENT AND CEOMAY - 15 - 2024
Page 2 >